Psidium cattleianum fruit extract prevents systemic alterations in an animal model of type 2 diabetes mellitus: comparison with metformin effects. (17th February 2023)
- Record Type:
- Journal Article
- Title:
- Psidium cattleianum fruit extract prevents systemic alterations in an animal model of type 2 diabetes mellitus: comparison with metformin effects. (17th February 2023)
- Main Title:
- Psidium cattleianum fruit extract prevents systemic alterations in an animal model of type 2 diabetes mellitus: comparison with metformin effects
- Authors:
- Cardoso, Juliane De Souza
Cardoso Teixeira, Fernanda
De Mello, Julia Eisenhardt
Soares De Aguiar, Mayara Sandrielly
Souto Oliveira, Pathise
Torchelsen Saraiva, Juliane
Vizzotto, Marcia
Borelli Grecco, Fabiane
Lencina, Claiton Leoneti
Spanevello, Roselia Maria
Tavares, Rejane Giacomelli
Stefanello, Francieli Moro - Abstract:
- Abstract: Objective: In this study, we aimed to determine the role of Psidium cattleianum extract (PCE) and compare its effects with those of metformin (Met) in an animal model with type 2 diabetes mellitus (T2DM). Methods: T2DM was induced in rats using a high-fat diet (HFD), followed by a single dose of streptozotocin (STZ). Met and PCE were administered intragastrically once a day throughout the experiment, and their effects on biochemical, inflammatory, oxidative, and histological parameters were evaluated. Results: Met and PCE prevented the increase in serum levels of glucose, total cholesterol (TC), triacylglycerol (TG), very low-density lipoprotein (VLDL) and interleukin-6 (IL-6) induced by T2DM, and restored redox homeostasis in the liver and brain. Met increased the serum levels of anti-inflammatory cytokine and interleukin-10 (IL-10). Furthermore, both treatments restored the liver and pancreas from marked cellular disorganisation, vacuolisation, and necrosis, with PCE being more effective than Met in recovering histological changes. Conclusion: PCE is a promising agent for the prevention of T2DM complications.
- Is Part Of:
- Biomarkers. Volume 28:Number 2(2023)
- Journal:
- Biomarkers
- Issue:
- Volume 28:Number 2(2023)
- Issue Display:
- Volume 28, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 28
- Issue:
- 2
- Issue Sort Value:
- 2023-0028-0002-0000
- Page Start:
- 238
- Page End:
- 248
- Publication Date:
- 2023-02-17
- Subjects:
- Diabetes -- animal model -- metformin -- oxidative stress -- phenolic compounds
Biochemical markers -- Periodicals
610.28 - Journal URLs:
- http://informahealthcare.com/journal/bmk ↗
http://informahealthcare.com ↗
http://www.tandf.co.uk/journals/alphalist.html ↗ - DOI:
- 10.1080/1354750X.2022.2163695 ↗
- Languages:
- English
- ISSNs:
- 1354-750X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.704500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26115.xml